My Quote Request
6505-01-141-4883
20 Products
NDC46287-0507-04
OINTMENT BASE
NSN, MFG P/N
6505011414883
NSN
6505-01-141-4883
MFG
CAROLINA MEDICAL PRODUCTS COMPANY
Description
III PART NAME ASSIGNED BY CONTROLLING AGENCY: OINTMENT BASE 4OZ JAR
PRIMARY CONTAINER CONTENT QUANTITY: 4.000 OUNCES
PRIMARY CONTAINER TYPE: JAR
SPECIAL FEATURES: SHALL HAVE A SPECIFIC GRAVITY OF 0.90 TO 0.94 AND A PH OF 6.50 TO 7.50
Related Searches:
NDC45802-0612-04
OINTMENT BASE
NSN, MFG P/N
6505011414883
NSN
6505-01-141-4883
MFG
CLAY-PARK LABORATORIES INC
Description
III PART NAME ASSIGNED BY CONTROLLING AGENCY: OINTMENT BASE 4OZ JAR
PRIMARY CONTAINER CONTENT QUANTITY: 4.000 OUNCES
PRIMARY CONTAINER TYPE: JAR
SPECIAL FEATURES: SHALL HAVE A SPECIFIC GRAVITY OF 0.90 TO 0.94 AND A PH OF 6.50 TO 7.50
Related Searches:
0127-01-7
YEAST EXTRACT,ANALYZED REAGENT
NSN, MFG P/N
6505011415074
NSN
6505-01-141-5074
0127-01-7
YEAST EXTRACT,ANALYZED REAGENT
NSN, MFG P/N
6505011415074
NSN
6505-01-141-5074
MFG
DIFCO LABORATORIES
Description
PHYSICAL FORM: POWDER
PRIMARY CONTAINER CONTENT QUANTITY: 1.000 POUNDS
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
DIPROSONE
BETAMETHASONE DIPROPIONATE LOTION,USP
NSN, MFG P/N
6505011418029
NSN
6505-01-141-8029
DIPROSONE
BETAMETHASONE DIPROPIONATE LOTION,USP
NSN, MFG P/N
6505011418029
NSN
6505-01-141-8029
MFG
SCHERING CORP AN AFFIL OF SCHERING-PLOUGH CORP
Description
ACTIVE INGREDIENT AND STRENGTH: 0.050 BETAMETHASONE DIPROPIONATE PERCENTAGE, W/V EQUIVALENT PER GRAM
III PART NAME ASSIGNED BY CONTROLLING AGENCY: BETAMETHASONE DIPROPIONATE LOTION USP 60ML PLASTIC BT
PRIMARY CONTAINER CONTENT QUANTITY: 60.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE WITH DROPPER TIP
SPECIAL FEATURES: 0.64 MG BETAMETHASONE DIPROPIONATE PER GRAM
Related Searches:
DIPROSONE LOTION
BETAMETHASONE DIPROPIONATE LOTION,USP
NSN, MFG P/N
6505011418029
NSN
6505-01-141-8029
DIPROSONE LOTION
BETAMETHASONE DIPROPIONATE LOTION,USP
NSN, MFG P/N
6505011418029
NSN
6505-01-141-8029
MFG
SCHERING CORP AN AFFIL OF SCHERING-PLOUGH CORP
Description
ACTIVE INGREDIENT AND STRENGTH: 0.050 BETAMETHASONE DIPROPIONATE PERCENTAGE, W/V EQUIVALENT PER GRAM
III PART NAME ASSIGNED BY CONTROLLING AGENCY: BETAMETHASONE DIPROPIONATE LOTION USP 60ML PLASTIC BT
PRIMARY CONTAINER CONTENT QUANTITY: 60.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE WITH DROPPER TIP
SPECIAL FEATURES: 0.64 MG BETAMETHASONE DIPROPIONATE PER GRAM
Related Searches:
NDC00093-0302-39
BETAMETHASONE DIPROPIONATE LOTION,USP
NSN, MFG P/N
6505011418029
NSN
6505-01-141-8029
NDC00093-0302-39
BETAMETHASONE DIPROPIONATE LOTION,USP
NSN, MFG P/N
6505011418029
NSN
6505-01-141-8029
MFG
TEVA PHARMACEUTICALS USA INC. DBA GATE PHARMACEUTICALS
Description
ACTIVE INGREDIENT AND STRENGTH: 0.050 BETAMETHASONE DIPROPIONATE PERCENTAGE, W/V EQUIVALENT PER GRAM
III PART NAME ASSIGNED BY CONTROLLING AGENCY: BETAMETHASONE DIPROPIONATE LOTION USP 60ML PLASTIC BT
PRIMARY CONTAINER CONTENT QUANTITY: 60.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE WITH DROPPER TIP
SPECIAL FEATURES: 0.64 MG BETAMETHASONE DIPROPIONATE PER GRAM
Related Searches:
NDC00168-0057-60
BETAMETHASONE DIPROPIONATE LOTION,USP
NSN, MFG P/N
6505011418029
NSN
6505-01-141-8029
NDC00168-0057-60
BETAMETHASONE DIPROPIONATE LOTION,USP
NSN, MFG P/N
6505011418029
NSN
6505-01-141-8029
MFG
FOUGERA E AND CO
Description
ACTIVE INGREDIENT AND STRENGTH: 0.050 BETAMETHASONE DIPROPIONATE PERCENTAGE, W/V EQUIVALENT PER GRAM
III PART NAME ASSIGNED BY CONTROLLING AGENCY: BETAMETHASONE DIPROPIONATE LOTION USP 60ML PLASTIC BT
PRIMARY CONTAINER CONTENT QUANTITY: 60.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE WITH DROPPER TIP
SPECIAL FEATURES: 0.64 MG BETAMETHASONE DIPROPIONATE PER GRAM
Related Searches:
NDC45802-0021-46
BETAMETHASONE DIPROPIONATE LOTION,USP
NSN, MFG P/N
6505011418029
NSN
6505-01-141-8029
NDC45802-0021-46
BETAMETHASONE DIPROPIONATE LOTION,USP
NSN, MFG P/N
6505011418029
NSN
6505-01-141-8029
MFG
PERRIGO L COMPANY INC
Description
ACTIVE INGREDIENT AND STRENGTH: 0.050 BETAMETHASONE DIPROPIONATE PERCENTAGE, W/V EQUIVALENT PER GRAM
III PART NAME ASSIGNED BY CONTROLLING AGENCY: BETAMETHASONE DIPROPIONATE LOTION USP 60ML PLASTIC BT
PRIMARY CONTAINER CONTENT QUANTITY: 60.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE WITH DROPPER TIP
SPECIAL FEATURES: 0.64 MG BETAMETHASONE DIPROPIONATE PER GRAM
Related Searches:
CECLOR
CEFACLOR FOR ORAL SUSPENSION,USP
NSN, MFG P/N
6505011419488
NSN
6505-01-141-9488
CECLOR
CEFACLOR FOR ORAL SUSPENSION,USP
NSN, MFG P/N
6505011419488
NSN
6505-01-141-9488
MFG
ELI LILLY AND COMPANY DBA ELI LILLY
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 3.750 GRAMS CEFACLOR ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: CEFACLOR FOR ORAL SUSPENSION USP 125MG/5ML 150ML BT
PHYSICAL FORM: POWDER
PRIMARY CONTAINER CONTENT QUANTITY: POWDER SUFFICIENT TO PROVIDE 125 MG OF CEFACLOR PER 5 ML WHEN RECONSTITUTED TO 150 ML
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: BOTTLE W/CHILD-RESISTANT SAFETY CLOSURE OF SUFFICIENT CAPACITY TO HOLD 150 ML WITH ADEQUATE SHAKE SPACE
Related Searches:
NDC00002-5057-68
CEFACLOR FOR ORAL SUSPENSION,USP
NSN, MFG P/N
6505011419488
NSN
6505-01-141-9488
NDC00002-5057-68
CEFACLOR FOR ORAL SUSPENSION,USP
NSN, MFG P/N
6505011419488
NSN
6505-01-141-9488
MFG
ELI LILLY AND COMPANY DBA ELI LILLY
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 3.750 GRAMS CEFACLOR ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: CEFACLOR FOR ORAL SUSPENSION USP 125MG/5ML 150ML BT
PHYSICAL FORM: POWDER
PRIMARY CONTAINER CONTENT QUANTITY: POWDER SUFFICIENT TO PROVIDE 125 MG OF CEFACLOR PER 5 ML WHEN RECONSTITUTED TO 150 ML
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: BOTTLE W/CHILD-RESISTANT SAFETY CLOSURE OF SUFFICIENT CAPACITY TO HOLD 150 ML WITH ADEQUATE SHAKE SPACE
Related Searches:
NDC59772-7490-40
CEFACLOR FOR ORAL SUSPENSION,USP
NSN, MFG P/N
6505011419488
NSN
6505-01-141-9488
NDC59772-7490-40
CEFACLOR FOR ORAL SUSPENSION,USP
NSN, MFG P/N
6505011419488
NSN
6505-01-141-9488
MFG
BRISTOL-MYERS CO
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 3.750 GRAMS CEFACLOR ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: CEFACLOR FOR ORAL SUSPENSION USP 125MG/5ML 150ML BT
PHYSICAL FORM: POWDER
PRIMARY CONTAINER CONTENT QUANTITY: POWDER SUFFICIENT TO PROVIDE 125 MG OF CEFACLOR PER 5 ML WHEN RECONSTITUTED TO 150 ML
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: BOTTLE W/CHILD-RESISTANT SAFETY CLOSURE OF SUFFICIENT CAPACITY TO HOLD 150 ML WITH ADEQUATE SHAKE SPACE
Related Searches:
CECLOR
CEFACLOR FOR ORAL SUSPENSION,USP
NSN, MFG P/N
6505011419489
NSN
6505-01-141-9489
CECLOR
CEFACLOR FOR ORAL SUSPENSION,USP
NSN, MFG P/N
6505011419489
NSN
6505-01-141-9489
MFG
ELI LILLY AND COMPANY DBA ELI LILLY
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 10.000 GRAMS CEFALOR EQUIVALENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: CEFACLOR FOR ORAL SUSPENSION USP 250MG IN A 150ML BT
PHYSICAL FORM: POWDER
PRIMARY CONTAINER CONTENT QUANTITY: 250.000 MILLIGRAMS ACTIVE INGREDIENT
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: BOTTLE W/CHILD-RESISTANT SAFETY CLOSURE OF SUFFICIENT CAPACITY TO HOLD 150 ML WITH ADEQUATE SHAKE SPACE
Related Searches:
NDC00002-5058-68
CEFACLOR FOR ORAL SUSPENSION,USP
NSN, MFG P/N
6505011419489
NSN
6505-01-141-9489
NDC00002-5058-68
CEFACLOR FOR ORAL SUSPENSION,USP
NSN, MFG P/N
6505011419489
NSN
6505-01-141-9489
MFG
ELI LILLY AND COMPANY DBA ELI LILLY
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 10.000 GRAMS CEFALOR EQUIVALENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: CEFACLOR FOR ORAL SUSPENSION USP 250MG IN A 150ML BT
PHYSICAL FORM: POWDER
PRIMARY CONTAINER CONTENT QUANTITY: 250.000 MILLIGRAMS ACTIVE INGREDIENT
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: BOTTLE W/CHILD-RESISTANT SAFETY CLOSURE OF SUFFICIENT CAPACITY TO HOLD 150 ML WITH ADEQUATE SHAKE SPACE
Related Searches:
NDC59772-7492-40
CEFACLOR FOR ORAL SUSPENSION,USP
NSN, MFG P/N
6505011419489
NSN
6505-01-141-9489
NDC59772-7492-40
CEFACLOR FOR ORAL SUSPENSION,USP
NSN, MFG P/N
6505011419489
NSN
6505-01-141-9489
MFG
BRISTOL-MYERS CO
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 10.000 GRAMS CEFALOR EQUIVALENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: CEFACLOR FOR ORAL SUSPENSION USP 250MG IN A 150ML BT
PHYSICAL FORM: POWDER
PRIMARY CONTAINER CONTENT QUANTITY: 250.000 MILLIGRAMS ACTIVE INGREDIENT
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: BOTTLE W/CHILD-RESISTANT SAFETY CLOSURE OF SUFFICIENT CAPACITY TO HOLD 150 ML WITH ADEQUATE SHAKE SPACE
Related Searches:
G6454
KARAYA GUM POWDER
NSN, MFG P/N
6505011419490
NSN
6505-01-141-9490
MFG
CITY CHEMICAL LLC
Description
III PART NAME ASSIGNED BY CONTROLLING AGENCY: KARAYA GUM POWDER 1LB CONTAINER
PHYSICAL FORM: POWDER
PRIMARY CONTAINER CONTENT QUANTITY: 453.600 GRAMS OR 1.000 POUNDS
PRIMARY CONTAINER TYPE: ANY ACCEPTABLE
SPECIAL FEATURES: SUITABLE FOR COLOSTOMY
Related Searches:
MOXAM
MOXALACTAM DISODIUM FOR INJECTION,USP
NSN, MFG P/N
6505011422291
NSN
6505-01-142-2291
MOXAM
MOXALACTAM DISODIUM FOR INJECTION,USP
NSN, MFG P/N
6505011422291
NSN
6505-01-142-2291
MFG
ELI LILLY AND COMPANY DBA ELI LILLY
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: EQUIVALENT TO 2.000 GRAMS MOXALACTAM ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: MOXALACTAM DISODIUM FOR INJECTION USP 100S PG
PHYSICAL FORM: POWDER
PRIMARY CONTAINER CONTENT QUANTITY: 2.000 MILLILITERS AFTER RECONSTITUTION
PRIMARY CONTAINER TYPE: VIAL
TOTAL PRIMARY CONTAINER QUANTITY: 10
Related Searches:
NDC00002-7154-10
MOXALACTAM DISODIUM FOR INJECTION,USP
NSN, MFG P/N
6505011422291
NSN
6505-01-142-2291
NDC00002-7154-10
MOXALACTAM DISODIUM FOR INJECTION,USP
NSN, MFG P/N
6505011422291
NSN
6505-01-142-2291
MFG
ELI LILLY AND COMPANY DBA ELI LILLY
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: EQUIVALENT TO 2.000 GRAMS MOXALACTAM ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: MOXALACTAM DISODIUM FOR INJECTION USP 100S PG
PHYSICAL FORM: POWDER
PRIMARY CONTAINER CONTENT QUANTITY: 2.000 MILLILITERS AFTER RECONSTITUTION
PRIMARY CONTAINER TYPE: VIAL
TOTAL PRIMARY CONTAINER QUANTITY: 10
Related Searches:
ELIXOPHYLLIN SR
THEOPHYLLINE CAPSULES,USP
NSN, MFG P/N
6505011424748
NSN
6505-01-142-4748
ELIXOPHYLLIN SR
THEOPHYLLINE CAPSULES,USP
NSN, MFG P/N
6505011424748
NSN
6505-01-142-4748
MFG
BAYER HEALTHCARE PHARMACEUTICALS INC. DBA BERLICHEM
Description
(NON-CORE DATA) UNIT PACKAGE TYPE: BOX
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 250.000 MILLIGRAMS THEOPHYLLINE ACTIVE INGREDIENT
CAPSULE CONTENT FORM: ANY ACCEPTABLE
CAPSULE TYPE: ANY ACCEPTABLE
FEATURES PROVIDED: INDIVIDUALLY SEALED
PRIMARY CONTAINER TYPE: STRIP
SPECIAL FEATURES: ANHYDROUS;100 INDIVIDUALLY SEALED CAPSULES;LONG ACTION METHOD:EXTENDED RELEASE;PRIMARY CONTAINER CONTENT QTY:A/A;TOTAL PRIMARY CONTAINER QTY:A/A;
Related Searches:
NDC50419-0123-11
THEOPHYLLINE CAPSULES,USP
NSN, MFG P/N
6505011424748
NSN
6505-01-142-4748
NDC50419-0123-11
THEOPHYLLINE CAPSULES,USP
NSN, MFG P/N
6505011424748
NSN
6505-01-142-4748
MFG
BAYER HEALTHCARE PHARMACEUTICALS INC. DBA BERLICHEM
Description
(NON-CORE DATA) UNIT PACKAGE TYPE: BOX
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 250.000 MILLIGRAMS THEOPHYLLINE ACTIVE INGREDIENT
CAPSULE CONTENT FORM: ANY ACCEPTABLE
CAPSULE TYPE: ANY ACCEPTABLE
FEATURES PROVIDED: INDIVIDUALLY SEALED
PRIMARY CONTAINER TYPE: STRIP
SPECIAL FEATURES: ANHYDROUS;100 INDIVIDUALLY SEALED CAPSULES;LONG ACTION METHOD:EXTENDED RELEASE;PRIMARY CONTAINER CONTENT QTY:A/A;TOTAL PRIMARY CONTAINER QTY:A/A;
Related Searches:
NDC00364-0595-90
METRONIDAZOLE TABLETS,USP
NSN, MFG P/N
6505011424914
NSN
6505-01-142-4914
NDC00364-0595-90
METRONIDAZOLE TABLETS,USP
NSN, MFG P/N
6505011424914
NSN
6505-01-142-4914
MFG
SCHEIN PHARMACEUTICAL INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 250.000 MILLIGRAMS METRONIDAZOLE ACTIVE INGREDIENT
FEATURES PROVIDED: INDIVIDUALLY SEALED
III PART NAME ASSIGNED BY CONTROLLING AGENCY: METRONIDAZOLE TABLETS USP 250MG INDIVIDUALLY SEALED 100S PG
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: STRIP